Russia still facing disappearance of drugs from list of vital meds

10 November 2022
russia_pharmacy_big

The number of drugs that are disappearing from Russian pharmaceutical retail is steadily growing due to ongoing repartition of the market by the largest local players as well as Western sanctions against Russia.

In recent weeks, Russia has been faced with the shortage of antibiotics, which is observed both the case of high-priced and imported medicines and domestic drugs. According to the Russian Association of Independent Pharmacies, some of these drugs have not been delivered to pharmacies since summer. The situation is complicated by a significant growth of prices for the still remaining range.

Since the end of 2010s Russia has faced massive disappearance of some cheap and middle-priced drugs from the market due to low profitability of their supplies for producers and low prices for them, which are set by the state during public procurements. The ongoing war between Russia and Ukraine led to further deterioration of situation.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical